Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy

Acta Dermatovenerol Alp Pannonica Adriat. 2010 Dec;19(4):15-9.

Abstract

Scleromyxedema is a rare chronic cutaneous mucinosis usually associated with a monoclonal gammopathy and underlying systemic disease. The etiology of the disease is not known. There are no standard treatments and response to various therapeutic modalities varies. We report a case of refractory scleromyxedema in a 63-year-old man with a biclonal IgG and IgM λ-gammopathy. The patient was successfully managed with intravenous immunoglobulin.

Publication types

  • Case Reports

MeSH terms

  • Humans
  • Immunoglobulin G / analysis
  • Immunoglobulin M / analysis
  • Immunoglobulins, Intravenous / therapeutic use*
  • Immunologic Factors / therapeutic use*
  • Male
  • Middle Aged
  • Paraproteinemias / complications*
  • Scleromyxedema / complications
  • Scleromyxedema / drug therapy*
  • Scleromyxedema / pathology
  • Skin / pathology

Substances

  • Immunoglobulin G
  • Immunoglobulin M
  • Immunoglobulins, Intravenous
  • Immunologic Factors